Lu Hongbo
- SEC CIK
- 0001767584
In the past year, 4 open-market purchase filings worth $8.15M and 1 sale filing worth $228.3K.
Current role at each company
- ZBIO Zenas BioPharma, Inc.Directoras of Jun 17, 2026
- ARWR Arrowhead Pharmaceuticals, Inc.Directoras of May 14, 2026
- TERN Terns Pharmaceuticals, Inc.Directoras of Jun 12, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $8.15M
- 4 filings
- Sold
- $228.3K
- 1 filing
- Net
- +$7.93M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Lu Hongbo as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARWR Arrowhead Pharmaceuticals, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2024 (view filing) | Mar 18-20 | 2 days | Lu HongboDirector | PPurchase | +3.00K | $27.66 | +$83.0K | +9.8%33.7K after | 3 lots |
| May 14, 2026 (view filing) | May 12 | 2 days | Lu HongboDirector | SSale | −2.97K | $76.88 | −$228.3K | −5.4%52.0K after | 10b5-1 |
ZBIO Zenas BioPharma, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 (view filing) | Sep 13 | 4 days | Lu HongboDirector | PPurchase | +58.8K | $17.00 | +$1.00M | New position58.8K after | |
| Oct 9, 2025 (view filing) | Sep 13, 2024-Oct 7, 2025 | 391 daysLate | Lu HongboDirector | PPurchase | +322.0K | $18.63 | +$6.00M | New position322.0K after | 2 lots |
| Feb 13, 2026 (view filing) | Feb 11 | 2 days | Lu HongboDirector | PPurchase | +26.0K | $22.50 | +$584.7K | +8.1%348.0K after | |
| Mar 31, 2026 (view filing) | Mar 31 | Same day | Lu HongboDirector | PPurchase | +75.0K | $20.00 | +$1.50M | +21.6%423.0K after | |
| Apr 2, 2026 (view filing) | Mar 31 | 2 days | Lu HongboDirector | PPurchase | +3.77K | $18.63 | +$70.2K | +0.9%426.7K after |
TERN Terns Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 (view filing) | Aug 12-16 | 4 days | Lu HongboDirector | PPurchase | +2.62M | $2.66 | +$6.98M | +734.4%2.98M after | 3 lots |
| Aug 16, 2022 (view filing) | Aug 16 | Same day | Lu HongboDirector | PPurchase | +1.50M | $2.42 | +$3.63M | –1.50M after | Derivative |
| Sep 8, 2022 (view filing) | Sep 7 | 1 day | Lu HongboDirector | PPurchase | +600.0K | $3.60 | +$2.16M | +20.1%3.58M after | |
| Dec 23, 2022 (view filing) | Dec 23 | Same day | Lu HongboDirector | PPurchase | +758.6K | $7.25 | +$5.50M | +21.2%4.34M after | |
| Sep 17, 2024 (view filing) | Sep 12 | 5 daysLate | Lu HongboDirector | PPurchase | +476.2K | $10.50 | +$5.00M | New position476.2K after | 2 lots |